S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
$6.69
-7.7%
$0.00
$4.00
$9.86
$196.69M0.01330,199 shs420,871 shs
Medicure Inc. stock logo
MPH
Medicure
C$1.03
-4.6%
C$1.16
C$1.00
C$1.80
C$10.56M1.014,399 shs16,930 shs
Newfield Exploration stock logo
NFX
Newfield Exploration
$17.07
$0.00
$12.45
$31.46
$3.43B1.858.80 million shsN/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
0.00%0.00%+16.00%+54.13%-12.61%
Medicure Inc. stock logo
MPH
Medicure
-4.63%-4.63%-10.43%-20.16%-23.70%
Newfield Exploration stock logo
NFX
Newfield Exploration
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
1.0528 of 5 stars
3.51.00.00.02.50.00.6
Medicure Inc. stock logo
MPH
Medicure
N/AN/AN/AN/AN/AN/AN/AN/A
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
3.00
Buy$25.72284.45% Upside
Medicure Inc. stock logo
MPH
Medicure
N/AN/AN/AN/A
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/A

Current Analyst Ratings

Latest ATNM, MPH, FARN, and NFX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/1/2024
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$50.00
4/1/2024
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$21.00
3/26/2024
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$50.00
3/19/2024
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $30.00
3/19/2024
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$50.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
$80K2,458.58N/AN/A$1.31 per share5.11
Medicure Inc. stock logo
MPH
Medicure
C$22.94M0.46C$0.41 per share2.49C$2.10 per share0.49
Newfield Exploration stock logo
NFX
Newfield Exploration
$1.77B1.94$4.50 per share3.79$7.05 per share2.42

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
-$48.82M-$1.83N/A6.90N/AN/A-102.64%-52.57%5/15/2024 (Estimated)
Medicure Inc. stock logo
MPH
Medicure
C$1.08MC$0.0911.44N/A4.71%5.04%2.49%5/24/2024 (Estimated)
Newfield Exploration stock logo
NFX
Newfield Exploration
$427M$2.157.945.170.3721.14%43.65%13.21%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
N/AN/AN/AN/AN/A
Medicure Inc. stock logo
MPH
Medicure
N/AN/AN/AN/AN/A
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
N/A
9.21
9.21
Medicure Inc. stock logo
MPH
Medicure
2.86
2.28
1.29
Newfield Exploration stock logo
NFX
Newfield Exploration
1.30
0.72
0.70

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
27.50%
Medicure Inc. stock logo
MPH
Medicure
23.10%
Newfield Exploration stock logo
NFX
Newfield Exploration
97.87%

Insider Ownership

CompanyInsider Ownership
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
4.00%
Medicure Inc. stock logo
MPH
Medicure
26.99%
Newfield Exploration stock logo
NFX
Newfield Exploration
0.59%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Actinium Pharmaceuticals, Inc. stock logo
ATNM
Actinium Pharmaceuticals
4929.40 million28.22 millionNot Optionable
Medicure Inc. stock logo
MPH
Medicure
N/A10.25 millionN/ANot Optionable
Newfield Exploration stock logo
NFX
Newfield Exploration
N/A200.93 millionN/AOptionable

ATNM, MPH, FARN, and NFX Headlines

SourceHeadline
Offices inspired by the era of disco musicOffices inspired by the era of disco music
theplan.it - March 29 at 4:18 PM
New and used 2024 Acura Integra for sale near Newfield, NJNew and used 2024 Acura Integra for sale near Newfield, NJ
cars.com - March 23 at 2:54 AM
Microsoft could launch Surface Pro 10 and Surface Laptop 6 on March 21: ReportMicrosoft could launch Surface Pro 10 and Surface Laptop 6 on March 21: Report
gizmochina.com - March 6 at 4:11 PM
Microsoft Looks to Be Muscling In on Partner SegaMicrosoft Looks to Be Muscling In on Partner Sega
thestreet.com - December 28 at 12:42 AM
Boozy office holiday parties are going out of fashion as workers sip mocktails, non-alcoholic wine insteadBoozy office holiday parties are going out of fashion as workers sip mocktails, non-alcoholic wine instead
msn.com - December 22 at 9:58 PM
Khosla, Tiger, NEA, and 24 other VC firms warn of ‘destructive’ impact of FTC’s current M&A approachKhosla, Tiger, NEA, and 24 other VC firms warn of ‘destructive’ impact of FTC’s current M&A approach
aol.com - December 7 at 8:32 PM
Mana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate "Programmable Drug Delivery" for RNA and Gene TherapiesMana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate "Programmable Drug Delivery" for RNA and Gene Therapies
benzinga.com - October 10 at 12:58 PM
Newfield issues A$16.9m in new equityNewfield issues A$16.9m in new equity
miningweekly.com - September 29 at 12:38 PM
Why NFX Invested in Vendict: The Startup Behind the First Cybersecurity LLMWhy NFX Invested in Vendict: The Startup Behind the First Cybersecurity LLM
msn.com - August 14 at 8:21 AM
Will A.I. replace venture capitalists?Will A.I. replace venture capitalists?
msn.com - June 26 at 12:46 PM
Newfield Stock Falls On Unusually High Volume (NFX)Newfield Stock Falls On Unusually High Volume (NFX)
thestreet.com - May 28 at 12:11 AM
NFX’s James Currier: Where unicorn ideas come from and why founders ‘have to keep pivoting’NFX’s James Currier: Where unicorn ideas come from and why founders ‘have to keep pivoting’
msn.com - May 7 at 3:15 PM
Newfield High SchoolNewfield High School
usnews.com - May 1 at 7:56 AM
Newfield Hamlet, United States - Weather Forecasts | Maps | News - Yahoo WeatherNewfield Hamlet, United States - Weather Forecasts | Maps | News - Yahoo Weather
yahoo.com - April 30 at 5:26 AM
Utility Funds May Be Set to OutperformUtility Funds May Be Set to Outperform
thestreet.com - March 10 at 7:17 PM
Founder and NFX VC James Currier vets startup ideas at TC Early StageFounder and NFX VC James Currier vets startup ideas at TC Early Stage
msn.com - January 23 at 3:07 PM
The 5 Best Half-Life: Alyx Mods for Story and ExplorationThe 5 Best Half-Life: Alyx Mods for Story and Exploration
escapistmagazine.com - January 12 at 6:15 PM
Xternity, Backed by NFX, Secures $4.5 Million To Boost Web3 Adoption by WEB2 GamesXternity, Backed by NFX, Secures $4.5 Million To Boost Web3 Adoption by WEB2 Games
msn.com - November 7 at 5:04 PM
Newfield Senior High SchoolNewfield Senior High School
usnews.com - October 18 at 11:35 PM
Newfield, NY 10-Day Weather ForecastNewfield, NY 10-Day Weather Forecast
wunderground.com - October 12 at 10:54 PM
Newfield, NJ Weather ConditionsNewfield, NJ Weather Conditions
wunderground.com - October 11 at 4:31 PM
Newfield, NY Weather ConditionsNewfield, NY Weather Conditions
wunderground.com - September 27 at 12:08 AM
West Newfield, ME Weather ConditionsWest Newfield, ME Weather Conditions
wunderground.com - September 10 at 6:01 PM
Want more private firms to invest in mineral exploration: GovtWant more private firms to invest in mineral exploration: Govt
livemint.com - August 25 at 6:43 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Actinium Pharmaceuticals logo

Actinium Pharmaceuticals

NYSEAMERICAN:ATNM
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted radiotherapies to deliver cancer-killing radiation to treat patients with high unmet medical needs. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for bone marrow transplant conditioning; and a Phase I study with a CD19- targeted CAR T-cell therapy with memorial sloan kettering cancer center. The company also offers clinical and preclinical development programs that utilize multiple isotopes, including Actinium-225, Iodine-131, and Lutetium-177 directed at multiple targets in oncology and hematology, including CD45, CD33, HER3, and other. It has collaboration with Astellas Pharma, Inc. to develop theranostics for solid tumor indications; EpicentRx, Inc that focuses on a novel CD47 immunotherapy targeted radiotherapy; and AVEO Oncology that focuses on developing a HER3 targeting ARC for solid tumors. The company is based in New York, New York.
Medicure logo

Medicure

CVE:MPH
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.
Newfield Exploration logo

Newfield Exploration

NYSE:NFX
Newfield Exploration Company, an independent energy company, engages in the exploration, development, and production of crude oil, natural gas, and natural gas liquids in the United States. The company has operations principally in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota, and the Uinta Basin of Utah. It also holds oil producing assets offshore China. The company was founded in 1988 and is headquartered in The Woodlands, Texas.